CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B953. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 1 | -98.6% | 0.00% | – |
| Q1 2018 | $7,000 | -36.4% | 74 | -66.8% | 0.00% | – |
| Q4 2017 | $11,000 | -35.3% | 223 | +34.3% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | -32.0% | 166 | -17.0% | 0.00% | 0.0% |
| Q2 2017 | $25,000 | +47.1% | 200 | -28.6% | 0.00% | 0.0% |
| Q1 2017 | $17,000 | -57.5% | 280 | +127.6% | 0.00% | -50.0% |
| Q4 2016 | $40,000 | -71.4% | 123 | -54.6% | 0.00% | -77.8% |
| Q3 2016 | $140,000 | -4.1% | 271 | +4.2% | 0.01% | -10.0% |
| Q2 2016 | $146,000 | -33.3% | 260 | -44.6% | 0.01% | -41.2% |
| Q1 2016 | $219,000 | +284.2% | 469 | +266.4% | 0.02% | +325.0% |
| Q4 2015 | $57,000 | -53.3% | 128 | -24.3% | 0.00% | -55.6% |
| Q3 2015 | $122,000 | +190.5% | 169 | +36.3% | 0.01% | +125.0% |
| Q2 2015 | $42,000 | +121.1% | 124 | -39.8% | 0.00% | +100.0% |
| Q1 2015 | $19,000 | -20.8% | 206 | -58.9% | 0.00% | -33.3% |
| Q4 2014 | $24,000 | – | 501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 105,500 | $373,000 | 0.00% |
| SIMPLEX TRADING, LLC | 123 | $40,000 | 0.00% |